Publication:
Genotype-Phenotype Correlation of β-Thalassemia in Malaysian Population: Toward Effective Genetic Counseling

dc.contributor.authorUday Y.H. Abdullahen_US
dc.contributor.authorHishamshah M. Ibrahimen_US
dc.contributor.authorNoraesah Binti Mahmuden_US
dc.contributor.authorMohamad Zaki Sallehen_US
dc.contributor.authorLay Kek Tehen_US
dc.contributor.authorMohd Nur Fakhruzzaman bin Noorizhaben_US
dc.contributor.authorBin Alwi Zilfalilen_US
dc.contributor.authorHaitham Muhammed Jassimen_US
dc.contributor.authorPrapin Wilairaten_US
dc.contributor.authorSuthat Fucharoenen_US
dc.contributor.otherSouth Metropolitan Health Serviceen_US
dc.contributor.otherUniversiti Sultan Zainal Abidinen_US
dc.contributor.otherKuala Lumpur Hospitalen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversiti Teknologi MARAen_US
dc.contributor.otherSchool of Medical Sciences - Universiti Sains Malaysiaen_US
dc.date.accessioned2020-08-25T09:06:49Z
dc.date.available2020-08-25T09:06:49Z
dc.date.issued2020-05-03en_US
dc.description.abstract© 2020 Informa UK Limited, trading as Taylor & Francis Group. Effective prevention of β-thalassemia (β-thal) requires strategies to detect at-risk couples. This is the first study attempting to assess the prevalence of silent β-thal carriers in the Malaysian population. Hematological and clinical parameters were evaluated in healthy blood donors and patients with β-thal trait, Hb E (HBB: c.79G>A)/β-thal and β-thal major (β-TM). β-Globin gene sequencing was carried out for 52 healthy blood donors, 48 patients with Hb E/β-thal, 34 patients with β-TM and 38 patients with β-thal trait. The prevalence of silent β-thal carrier phenotypes found in 25.0% of healthy Malaysian blood donors indicates the need for clinician’s awareness of this type in evaluating β-thal in Malaysia. Patients with β-TM present at a significantly younger age at initial diagnosis and require more blood transfusions compared to those with Hb E/β-thal. The time at which genomic DNA was extracted after blood collection, particularly from patients with β-TM and Hb E/β-thal, was found to be an important determinant of the quality of the results of the β-globin sequencing. Public education and communication campaigns are recommended as apparently healthy individuals have few or no symptoms and normal or borderline hematological parameters. β-Globin gene mutation characterization and screening for silent β-thal carriers in regions prevalent with β-thal are recommended to develop more effective genetic counseling and management of β-thal.en_US
dc.identifier.citationHemoglobin. Vol.44, No.3 (2020), 184-189en_US
dc.identifier.doi10.1080/03630269.2020.1781652en_US
dc.identifier.issn1532432Xen_US
dc.identifier.issn03630269en_US
dc.identifier.other2-s2.0-85087180198en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/57735
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85087180198&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectMedicineen_US
dc.titleGenotype-Phenotype Correlation of β-Thalassemia in Malaysian Population: Toward Effective Genetic Counselingen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85087180198&origin=inwarden_US

Files

Collections